STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 90 filers reported holding STEMLINE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 15.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $66,376 | -47.9% | 13,714 | +14.4% | 0.00% | -50.0% |
Q4 2019 | $127,401 | -8.4% | 11,985 | -10.3% | 0.00% | 0.0% |
Q3 2019 | $139,057 | -32.0% | 13,358 | 0.0% | 0.00% | -33.3% |
Q2 2019 | $204,645 | +19.2% | 13,358 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $171,650 | +112.0% | 13,358 | +56.7% | 0.00% | +50.0% |
Q4 2018 | $80,969 | -42.8% | 8,523 | 0.0% | 0.00% | -33.3% |
Q3 2018 | $141,482 | -99.9% | 8,523 | 0.0% | 0.00% | +50.0% |
Q2 2018 | $136,794,000 | +10.5% | 8,523 | +5.4% | 0.00% | 0.0% |
Q1 2018 | $123,762,000 | +98123.8% | 8,089 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $126,000 | -28.0% | 8,089 | -48.7% | 0.00% | +100.0% |
Q3 2017 | $175,000 | -5.4% | 15,763 | +23.5% | 0.00% | 0.0% |
Q1 2015 | $185,000 | +14.2% | 12,765 | +60.0% | 0.00% | 0.0% |
Q1 2014 | $162,000 | +3.8% | 7,976 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $156,000 | -56.8% | 7,976 | 0.0% | 0.00% | -66.7% |
Q3 2013 | $361,000 | +90.0% | 7,976 | 0.0% | 0.00% | +50.0% |
Q2 2013 | $190,000 | – | 7,976 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lyon Street Capital, LLC | 762,941 | $7,248,000 | 7.29% |
NEXTHERA CAPITAL LP | 711,558 | $6,760,000 | 2.79% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 585,930 | $4,366,000 | 2.71% |
Consonance Capital Management LP | 1,155,793 | $10,980,000 | 0.81% |
Pier Capital, LLC | 423,667 | $4,025,000 | 0.80% |
KNOTT DAVID M | 155,795 | $1,480,000 | 0.70% |
Eventide Asset Management | 1,086,400 | $10,321,000 | 0.46% |
Empire Life Investments Inc. | 373,863 | $3,552,000 | 0.32% |
Telemetry Investments, L.L.C. | 41,588 | $395,000 | 0.25% |
Polar Capital LLP | 2,302,666 | $21,875,000 | 0.23% |